INFI News and Press, Infinity Pharmaceuticals Inc. From 06/27/19

Oppenheimer initiates coverage on thinly traded nano cap Infinity Pharmaceuticals ( INFI +3.6% ) with an Outperform rating and $3 (74% upside) price target. More news on: Infinity Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...

CAMBRIDGE, Mass. , May 29, 2019 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) announced today that members of the management team will be participating in the 2019 BIO International Convention at Pennsylvania Convention Center, Philadelphia, PA. Adelene Perkins , ...

CAMBRIDGE, Mass. , May 16, 2019 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) announced today that Adelene Perkins , Infinity Pharmaceutical's Chief Executive Officer, will present at the B. Riley FBR Institutional Investor Conference on Thursday, May 23, 2019 , at ...

Infinity Pharmaceuticals, Inc. (INFI) Q1 2019 Earnings Conference Call May 07, 2019 04:30 PM ET Company Participants Jayne Kauffman - Senior Executive Coordinator Adelene Perkins - CEO Sam Agresta - Chief Medical Officer Jeff Kutok - Chief Scientific Officer Conference Call...

Infinity Pharmaceuticals (NASDAQ: INFI ): Q1 GAAP EPS of -$0.24 misses by $0.08 . More news on: Infinity Pharmaceuticals, Inc., Earnings news and commentary, Consumer stocks news, , Read more ...

CAMBRIDGE, Mass. , May 7, 2019 /PRNewswire/ --  Infinity Pharmaceuticals, Inc.  (NASDAQ: INFI) today announced its first quarter 2019 financial results and provided an update on the company, including its progress in expanding the breadth and depth of the development of IPI-549 ...

CAMBRIDGE, Mass. , April 30, 2019 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Tuesday, May 7 , at 4:30 p.m. ET to review its first quarter 2019 financial results and provide an update on the company. A live webcast of the confere...

CAMBRIDGE, Mass. , April 2, 2019 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) announced today that Adelene Perkins , Infinity Pharmaceutical's Chief Executive Officer, will present at the 18 th Annual Needham Healthcare Conference on Tuesday, April 9, 2019 , at 3...

Infinity Pharmaceuticals Inc. (INFI) Q4 2018 Results Earnings Conference Call March 14, 2019 08:00 AM ET Company Participants Jayne Kauffman - Senior Executive Coordinator Adelene Perkins - CEO Samuel Agresta - CMO Lawrence Bloch - President Jeffery Kutok - Chief Scientific...

Atossa Genetics (NASDAQ: ATOS ) +223%  on expanded access for Endoxifen. More news on: Atossa Genetics Inc., Hancock Jaffe Laboratories, Inc., Safe-T Group Ltd, Stocks on the move, Read more ...